Perioperative medicine & outcomes

Development and internal validation of models to predict postoperative troponin and myocardial injury after noncardiac surgery by incorporating hypotension as a predictor: single-centre retrospective cohort study

BJA OpenPublished Retrospective cohort study

Authors' conclusion

A model including postoperative hypotension to predict postoperative troponin concentrations fits our data well, but did not show sufficient accuracy and is not ready for clinical practice.

Study context

Population
Patients aged ≥45 yr undergoing inpatient noncardiac surgery, St. Paul's Hospital, Canada, 2020–2021
Participants
846 patients
Outcome
Maximum troponin concentration on PODs 1-3 (primary model)
Follow-up
PODs 1-3
Methodological detailssingle-centre, prediction model development and internal validation, repeated patient-based five-fold cross-validation with 100 repetitions
  • Single-centre
  • Prediction model development and internal validation
  • Repeated patient-based five-fold cross-validation with 100 repetitions

Main finding

As reported in the abstract

Primary model for log-transformed troponin (internal validation)

Conditional R2

0.94

Marginal R2

0.20

Cross-validated root mean square error (RMSE)

0.90

Observational data: associations, not effects.

Further findings

MINS incidence between postoperative days (PODs) 0 and 3

Patients developing MINS (299 of 846)
35%

MINS model (secondary model), internally validated

AUC
0.69 (95% CI 0.63-0.75)

Inclusion of intraoperative hypotension

Did not improve prediction of troponin or MINS

Original publication

Development and internal validation of models to predict postoperative troponin and myocardial injury after noncardiac surgery by incorporating hypotension as a predictor: single-centre retrospective cohort study. BJA Open. Published 28 July 2026. doi:10.1016/j.bjao.2026.100644

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.